DE60027168D1 - Adrenomedullin zur behandlung von störungen des harnlassens - Google Patents

Adrenomedullin zur behandlung von störungen des harnlassens

Info

Publication number: DE60027168D1
Authority: DE; Germany
Prior art keywords: adrenomedullin; incontinence; urination disorder; composition; harnlass
Prior art date: 1999-06-23
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

DE60027168T

Other languages

English (en)

Other versions

DE60027168T2 (de

Inventor

Toshihiko Yanagita

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

KANGAWA, KENJI, MINO-SHI, OSAKA, JP

Original Assignee

Shionogi and Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-06-23

Filing date

2000-06-23

Publication date

2006-05-18

2000-06-23 Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd

2006-05-18 Application granted granted Critical

2006-05-18 Publication of DE60027168D1 publication Critical patent/DE60027168D1/de

2007-01-11 Publication of DE60027168T2 publication Critical patent/DE60027168T2/de

2020-06-24 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

102000004379 Adrenomedullin Human genes 0.000 title abstract 4
101800004616 Adrenomedullin Proteins 0.000 title abstract 4
ULCUCJFASIJEOE-NPECTJMMSA-N adrenomedullin Chemical compound C([C@@H](C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)NCC(=O)N[C@@H]1C(N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CSSC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(N)=O)[C@@H](C)O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=CC=C1 ULCUCJFASIJEOE-NPECTJMMSA-N 0.000 title abstract 4
208000028938 Urination disease Diseases 0.000 abstract 4
206010021639 Incontinence Diseases 0.000 abstract 1
208000000921 Urge Urinary Incontinence Diseases 0.000 abstract 1
206010046543 Urinary incontinence Diseases 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
229940079593 drug Drugs 0.000 abstract 1
208000024449 overflow incontinence Diseases 0.000 abstract 1
230000001737 promoting effect Effects 0.000 abstract 1
230000011514 reflex Effects 0.000 abstract 1
210000002460 smooth muscle Anatomy 0.000 abstract 1
206010046494 urge incontinence Diseases 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Urology & Nephrology (AREA)
Epidemiology (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Endocrinology (AREA)
Zoology (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Pain & Pain Management (AREA)
Neurology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Steroid Compounds (AREA)
Medicines Containing Plant Substances (AREA)
Electrotherapy Devices (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DE60027168T 1999-06-23 2000-06-23 Adrenomedullin zur behandlung von störungen des harnlassens Expired - Fee Related DE60027168T2 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP17754999		1999-06-23
JP17754999		1999-06-23
PCT/JP2000/004166 WO2000078338A1 (fr)	1999-06-23	2000-06-23	Compositions favorisant l'allongement passif des muscles lisses vesiculaires

Publications (2)

Publication Number	Publication Date
DE60027168D1 true DE60027168D1 (de)	2006-05-18
DE60027168T2 DE60027168T2 (de)	2007-01-11

Family

ID=16032903

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE60027168T Expired - Fee Related DE60027168T2 (de)	1999-06-23	2000-06-23	Adrenomedullin zur behandlung von störungen des harnlassens

Country Status (6)

Country	Link
US (1)	US6852692B1 (de)
EP (1)	EP1205186B1 (de)
JP (1)	JP4610142B2 (de)
AT (1)	ATE322284T1 (de)
DE (1)	DE60027168T2 (de)
WO (1)	WO2000078338A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2007534611A (ja) *	2003-04-08	2007-11-29	ジェノバ・リミテッド	心臓血管障害に関連する分泌ポリペプチド種
EP1620734A1 (de) *	2003-04-25	2006-02-01	Genova Ltd.	Ausgeschiedene polypeptide mit reduzierter konzentration bei kardiovasculären krankheiten
CN101945659A (zh)	2008-02-19	2011-01-12	国立大学法人旭川医科大学	肾上腺髓质素产生增强剂

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2774769B2 (ja) *	1993-04-26	1998-07-09	賢治寒川	アドレノメデュリン
EP0777684B1 (de) *	1994-08-16	2004-04-28	Human Genome Sciences, Inc.	Calcitoninrezeptor
US5888963A (en)	1996-04-18	1999-03-30	Auckland Uniservices Limited	Treatment of bone disorders with adrenomedullin
AU4251301A (en) *	2000-03-24	2001-10-03	Bayer Aktiengesellschaft	Regulation of human nerve growth factor-elated g protein-coupled receptor

2000
- 2000-06-23 EP EP00940830A patent/EP1205186B1/de not_active Expired - Lifetime
- 2000-06-23 DE DE60027168T patent/DE60027168T2/de not_active Expired - Fee Related
- 2000-06-23 WO PCT/JP2000/004166 patent/WO2000078338A1/ja not_active Ceased
- 2000-06-23 JP JP2001504401A patent/JP4610142B2/ja not_active Expired - Fee Related
- 2000-06-23 AT AT00940830T patent/ATE322284T1/de not_active IP Right Cessation
- 2000-06-23 US US10/018,924 patent/US6852692B1/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EP1205186A1 (de)	2002-05-15
JP4610142B2 (ja)	2011-01-12
DE60027168T2 (de)	2007-01-11
EP1205186B1 (de)	2006-04-05
US6852692B1 (en)	2005-02-08
EP1205186A4 (de)	2003-06-25
WO2000078338A1 (fr)	2000-12-28
ATE322284T1 (de)	2006-04-15

Similar Documents

Publication	Publication Date	Title
DE69833059D1 (de)	2006-02-02	Verwendung von Botulinumtoxin zur Behandlung von Harninkontinenz
DE69739792D1 (de)	2010-04-15	Verfahren zur Behandlung von Augenerkrankungen
FR2836820B1 (fr)	2004-12-17	Dispositif chirurgical et bandelette pour le traitement de l'incontinence urinaire d'effort chez la femme
DE60023043D1 (de)	2006-02-16	(S,S)-Reboxetin zur Behandlung von Inkontinenz
MXPA03000436A (es)	2003-06-24	Medicamentos que compreden derivados de dicianopiridina.
DE69725484D1 (de)	2003-11-20	Vorrichtung zur Behandlung von Harninkontinenz
PL348097A1 (en)	2001-12-17	Application of biochemical substances in compositions for preventing occurrence and treating pathogenous states caused by muscular contraction of smooth muscles in body organs
NO20065380L (no)	2002-05-15	Anvendelse av R-(+)-2-(3-diisopropylamino-l-fenylpropyl)-4-hydroksymetyl-fenylisosmorsyrehydrogenfumarat for fremstilling av et medikament for behandling av urininkontinens og andre spasmogeniske sykdommer.
FR2804010B1 (fr)	2002-08-02	Dispositif percutane pour le traitement de l'incontinence urinaire d'effort de la femme par bandelette sous uretrale
ATE437630T1 (de)	2009-08-15	Vorrichtung und methode zur behandlung von urininkontinenz bei frauen
DE69616376D1 (de)	2001-11-29	Verwendung von Tiagabin zur Behandlung von Schlafstörungen
DE69210654D1 (de)	1996-06-20	Verwendung von Tomoxetine zur Behandlung von Funktionsstörungen der niedrigen Harnwege
ATE333874T1 (de)	2006-08-15	Konjugierte linolensäure zur behandlung von cyclooxygenase-2 vermittelten entzündungen und schmerzen
WO2001024783A3 (de)	2002-02-28	Verwendung von (+)-tramadol, o-demethyltramadol bzw. (+)-o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol bzw. (+)-o-desmethyl-n-mono-desmethyl-tramadol zur therapie der harninkontinenz
ATE422357T1 (de)	2009-02-15	Verwendung von allopurinol zur behandlung von bluthochdruck
DE60027168D1 (de)	2006-05-18	Adrenomedullin zur behandlung von störungen des harnlassens
BR0115882A (pt)	2003-12-02	Emprego de compostos de 1-fenil-3-dimetilaminopropano no tratamento da incontinência urinária
ATE252383T1 (de)	2003-11-15	Verwendung von 2-methyl-thiazolidin-2,4- dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen
ATE540742T1 (de)	2012-01-15	Zusammensetzung zur wasserbehandlung und verfahren zu deren herstellung
NO20012569L (no)	2001-07-25	Anvendelse av aryl-substituerte syklobutylalkylaminer for behandling av urininkontinens
DK1244438T3 (da)	2004-02-23	Anvendelse af beta-adrenoceptorantagonister til fremstilling af et medikament til behandling af sygdomme i den ydre nethinde
ATE345121T1 (de)	2006-12-15	Verwendung von konjugierter linolsäure zur behandlung der erkältung
DE50106546D1 (de)	2005-07-21	Zubereitung von cimicifuga racemosa zur behandlung der inkontinenz
WO2002043712A3 (de)	2002-08-01	Verwendung von 6-dimethylaminomethyl-1-phenyl-cyclohexanverbindungen zur therapie der harninkontinenz
IL162776A0 (en)	2005-11-20	2'-Halo-3',5'-dialkoxyphen-1'-yl-imino-2-imidazolidine derivatives and the use thereof for the treatment of urinary incontinence

Legal Events

Date	Code	Title	Description
2007-04-26	8364	No opposition during term of opposition
2009-11-05	8327	Change in the person/name/address of the patent owner	Owner name: KANGAWA, KENJI, MINO-SHI, OSAKA, JP
2010-04-22	8339	Ceased/non-payment of the annual fee